UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 95

Sortiert nach

The immunology of renal cell carcinoma

Nature reviews. Nephrology, 2020-12, Vol.16 (12), p.721

2020

Link zum Volltext

Verfügbarkeit prüfen

Recovery from Cyclophosphamide-Induced Lymphopenia Results in Expansion of Immature Dendritic Cells Which Can Mediate Enhanced Prime-Boost Vaccination Antitumor Responses In Vivo When Stimulated with the TLR3 Agonist Poly(I:C)

The Journal of immunology (1950), 2009-02, Vol.182 (4), p.2030-2040

2009

Link zum Volltext

Verfügbarkeit prüfen

PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activation

European journal of cancer (1990), 2006-07, Vol.42 (10), p.1491-1500

2006

Link zum Volltext

Verfügbarkeit prüfen

Cyclophosphamide Induces Dynamic Alterations in the Host Microenvironments Resulting in a Flt3 Ligand-Dependent Expansion of Dendritic Cells

The Journal of immunology (1950), 2010-02, Vol.184 (4), p.1737-1747

2010

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of rebounding of lymphoid and myeloid cells in mouse peripheral blood, spleen and bone marrow after treatment with cyclophosphamide

Cellular immunology, 2012-03, Vol.276 (1-2), p.67-74

2012

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer

Cancer biology & therapy, 2006-11, Vol.5 (11), p.1494-1501

2006

Link zum Volltext

Verfügbarkeit prüfen

Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series

Journal for immunotherapy of cancer, 2018-05, Vol.6 (1), p.36-36, Article 36

2018

Link zum Volltext

Verfügbarkeit prüfen

Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α

Clinical cancer research, 2017-05, Vol.23 (9), p.2346-2355

2017

Link zum Volltext

Verfügbarkeit prüfen

Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs

Cancer immunology research, 2019-10, Vol.7 (10), p.1687-1699

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with Melanoma

Clinical cancer research, 2024-02, Vol.30 (3), p.564

2024

Link zum Volltext

Verfügbarkeit prüfen

Immune-Checkpoint Blockade Opposes CD8 + T-cell Suppression in Human and Murine Cancer

Cancer immunology research, 2019-03, Vol.7 (3), p.510-525

2019

Link zum Volltext

Verfügbarkeit prüfen

Understanding the biology of ex vivo-expanded CD8 T cells for adoptive cell therapy: role of CD62L

Immunologic research, 2013-12, Vol.57 (1-3), p.23-33

2013

Link zum Volltext

Verfügbarkeit prüfen

α4 integrin increases anoikis of human osteosarcoma cells

Journal of cellular biochemistry, 2003-04, Vol.88 (5), p.1038-1047

2003

Link zum Volltext

Verfügbarkeit prüfen

Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents

BMC cancer, 2005-04, Vol.5 (1), p.39-39, Article 39

2005

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression

Oncoimmunology, 2023-12, Vol.12 (1), p.2198185-2198185

2023

Link zum Volltext

Verfügbarkeit prüfen

Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications

Seminars in oncology, 2014-04, Vol.41 (2), p.174-184

2014

Link zum Volltext

Verfügbarkeit prüfen

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy

Cancer Immunology, Immunotherapy, 2009-01, Vol.58 (1), p.49-59

2009

Link zum Volltext

Verfügbarkeit prüfen

Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma

Targeted oncology, 2018-10, Vol.13 (5), p.599-609

2018

Link zum Volltext

Verfügbarkeit prüfen

Immunobiology of Melanoma

Clinics in plastic surgery, 2021-10, Vol.48 (4), p.561-576

2021

Link zum Volltext

Verfügbarkeit prüfen

A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients

The Journal of experimental medicine, 2022-01, Vol.219 (1)

2022

Link zum Volltext

Verfügbarkeit prüfen

Old is new again: Emergence of thromboembolic complications in cancer patients on immunotherapy

Thrombosis research, 2022-05, Vol.213 (Suppl 1), p.S51-S57

2022

Link zum Volltext

Verfügbarkeit prüfen

Identification of CD8 T-Lymphocyte Epitopes in OmpB of Rickettsia conorii

Infection and Immunity, 2003-07, Vol.71 (7), p.3920-3926

2003

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma

Neuro-oncology (Charlottesville, Va.), 2019-03, Vol.21 (4), p.537-546

2019

Link zum Volltext

Verfügbarkeit prüfen

Increased incidence of venous thromboembolism with cancer immunotherapy

Med (New York, N.Y. : Online), 2021-04, Vol.2 (4), p.423-434.e3

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(95)

Sprache

Englisch
(95)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(36)
Science & Technology
(36)
Humans
(25)
Oncology
(22)
Animals
(18)
Immunology
(17)
Mice
(17)
Immunotherapy
(16)
Lymphocytes
(12)
Cancer
(9)
Female
(9)
Male
(9)
Tumors
(9)
Cd8-Positive T-Lymphocytes - Immunology
(8)
Flow Cytometry
(8)
Melanoma
(7)
Metastasis
(7)
Antigens
(6)
Biological And Medical Sciences
(6)
Cell Line, Tumor
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The immunology of renal cell carcinoma

Recovery from Cyclophosphamide-Induced Lymphopenia Results in Expansion of Immature Dendritic Cells Which Can Mediate Enhanced Prime-Boost Vaccination Antitumor Responses In Vivo When Stimulated with the TLR3 Agonist Poly(I:C)

PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activation

Cyclophosphamide Induces Dynamic Alterations in the Host Microenvironments Resulting in a Flt3 Ligand-Dependent Expansion of Dendritic Cells

Kinetics of rebounding of lymphoid and myeloid cells in mouse peripheral blood, spleen and bone marrow after treatment with cyclophosphamide

Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer

Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series

Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α

Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs

Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with Melanoma

Immune-Checkpoint Blockade Opposes CD8 + T-cell Suppression in Human and Murine Cancer

Understanding the biology of ex vivo-expanded CD8 T cells for adoptive cell therapy: role of CD62L

α4 integrin increases anoikis of human osteosarcoma cells

Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression

Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy

Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma

Immunobiology of Melanoma

A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients

Old is new again: Emergence of thromboembolic complications in cancer patients on immunotherapy

Identification of CD8 T-Lymphocyte Epitopes in OmpB of Rickettsia conorii

Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma

Increased incidence of venous thromboembolism with cancer immunotherapy

Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Suchergebnisse filtern